Gyre Therapeutics (GYRE) Dividends payables (2022)
Gyre Therapeutics (GYRE) posted quarterly Dividends payables of $7.6 million for Q4 2022.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Dividends payables (2022) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Dividends payables for 1 consecutive years, with $7.6 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Dividends payables changed N/A year-over-year to $7.6 million; the TTM figure through Dec 2022 stood at $7.6 million (changed N/A YoY), while the FY2022 annual figure was $7.6 million, changed N/A from the prior year.
- Dividends payables steadied at $7.6 million in Q4 2022 per GYRE's latest filing.
- Across five years, Dividends payables topped out at $7.6 million in Q4 2022 and bottomed at $7.6 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn | - |